These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1846278)

  • 81. Hepatitis C viral infection in liver transplant patients: how bad is it really?
    Rakela J
    Gastroenterology; 1992 Jul; 103(1):338-9. PubMed ID: 1319371
    [No Abstract]   [Full Text] [Related]  

  • 82. Long-term persistence of hepatitis C virus antibodies in a single source outbreak.
    Dittmann S; Roggendorf M; Dürkop J; Wiese M; Lorbeer B; Deinhardt F
    J Hepatol; 1991 Nov; 13(3):323-7. PubMed ID: 1725527
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients.
    Fritsche C; Brandes JC; Delaney SR; Gallagher-Lepak S; Menitove JE; Rich L; Scannell C; Swanson P; Lee HH
    Transplantation; 1993 Jun; 55(6):1283-7. PubMed ID: 8516814
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment.
    Schvarcz R; von Sydow M; Weiland O
    Scand J Gastroenterol; 1990 Nov; 25(11):1175-80. PubMed ID: 2177220
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anti-HCV antibodies detected by ELISA in autoimmune and cryptogenic chronic liver disease.
    Cassani F; Ballardini G; Fusconi M; Lenzi M; Volta U; Zauli D; Bianchi FB
    J Hepatol; 1991 Mar; 12(2):269-70. PubMed ID: 1646838
    [No Abstract]   [Full Text] [Related]  

  • 86. HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation.
    Lin SH; Wu KT; Wang CC; Huang KT; Chen KD; Lin CC; Hsu LW; Chiu KW
    J Int Med Res; 2021 Aug; 49(8):3000605211034945. PubMed ID: 34344219
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center.
    Goetz AM; Ndimbie OK; Wagener MM; Muder RR
    Transplantation; 1995 Apr; 59(7):990-4. PubMed ID: 7535961
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Follow-up of patients with hepatitis non-A, non-B: incidence and persistence of anti-HCV depend on route of transmission.
    Gmelin K; Kurzen F; Kallinowski B; Goeser T; Arnold J; Kommerell B; Theilmann L
    Arch Virol Suppl; 1992; 4():222-6. PubMed ID: 1450691
    [TBL] [Abstract][Full Text] [Related]  

  • 89. False-positive anti-HCV in biliary cirrhosis.
    Housset C; Hirschauer C; Degos F
    Ann Intern Med; 1991 Feb; 114(3):252. PubMed ID: 1845839
    [No Abstract]   [Full Text] [Related]  

  • 90. Toga virus-like particles in acute liver failure attributed to sporadic non-A, non-B hepatitis and recurrence after liver transplantation.
    Fagan EA; Ellis DS; Tovey GM; Lloyd G; Smith HM; Portmann B; Tan KC; Zuckerman AJ; Williams R
    J Med Virol; 1992 Sep; 38(1):71-7. PubMed ID: 1328513
    [TBL] [Abstract][Full Text] [Related]  

  • 91. True positive anti-HCV tests in rheumatoid arthritis.
    Baffoni L; Frisoni M; Miniero R; Righetti F; Sprovieri G; Ferri S
    Br J Rheumatol; 1993 Apr; 32(4):349-50. PubMed ID: 8384912
    [No Abstract]   [Full Text] [Related]  

  • 92. Natural course of HCV viremia following liver transplantation and clinical course of reinfection.
    Safadi R; Shouval D; Ashur Y; Eid A; Jurim O; Livni N; Galun E
    Transplant Proc; 1997 Sep; 29(6):2635-9. PubMed ID: 9290771
    [No Abstract]   [Full Text] [Related]  

  • 93. Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting.
    Ferrarese A; Sciarrone S; Gambato M; Germani G; Senzolo M; Boccagni P; Cillo U; Burra P; Russo FP
    Aliment Pharmacol Ther; 2020 Feb; 51(4):482-483. PubMed ID: 31990393
    [No Abstract]   [Full Text] [Related]  

  • 94. Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment.
    Nakamura M; Kanda T; Miyamura T; Wu S; Nakamoto S; Yokosuka O
    Int J Med Sci; 2013; 10(8):1015-21. PubMed ID: 23801888
    [TBL] [Abstract][Full Text] [Related]  

  • 95. High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.
    Jones LA; Clancy LE; Rawlinson WD; White PA
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3019-27. PubMed ID: 16940097
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages.
    Prince MI; Hudson M
    Postgrad Med J; 2002 Mar; 78(917):135-41. PubMed ID: 11884694
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Liver transplantation in patients with chronic hepatitis C and alcoholism.
    Dhar S; Omran L; Bacon BR; Solomon H; Di Bisceglie AM
    Dig Dis Sci; 1999 Oct; 44(10):2003-7. PubMed ID: 10548350
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hepatitis C virus recurrence after liver transplantation.
    Bizollon T; Ducerf C; Trepo C; Mutimer D
    Gut; 1999 Apr; 44(4):575-8. PubMed ID: 10075968
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.
    Gayowski T; Singh N; Marino IR; Vargas H; Wagener M; Wannstedt C; Morelli F; Laskus T; Fung JJ; Rakela J; Starzl TE
    Transplantation; 1997 Aug; 64(3):422-6. PubMed ID: 9275107
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The prevalence of hepatitis C virus (HCV) in infants and children after liver transplantation.
    Nowicki MJ; Ahmad N; Heubi JE; Kuramoto IK; Baroudy BM; Balistreri WF
    Dig Dis Sci; 1994 Oct; 39(10):2250-4. PubMed ID: 7924751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.